Target intelligence / Profile preview

Phosphoglycerate mutase 1 pseudogene 13 (PGAM1P13)

Target: PGAM1P13
Molecular classification: Pseudogene

Overview

Phosphoglycerate mutase 1 pseudogene 13 (PGAM1P13) is a human pseudogene lacking protein-coding function, derived from the PGAM1 locus[1][2]. While PGAM1 is a metabolic enzyme involved in glycolysis and considered a cancer therapeutic target[3][5], PGAM1P13 does not encode a protein and is not classified as a receptor, enzyme, transporter, or any druggable entity. Pseudogenes like PGAM1P13 generally arise through gene duplication or retrotransposition followed by disabling mutations[4]. PGAM1P13 is only annotated and tracked in genomic databases (e.g., NCBI Gene, Ensembl) for completeness, but is not itself a biological target for drug discovery or therapy.

Other names: PGAM1P13

Beyond the preview

Go deeper on Phosphoglycerate mutase 1 pseudogene 13 (PGAM1P13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphoglycerate mutase 1 pseudogene 13 (PGAM1P13).

Explore the full profile